After shares of CBRE plunged earlier this month on worries artificial intelligence will upend the need for office space, UBS thinks the fears are overblown and is recommending investors buy the stock after the retreat. The Swiss bank upgraded the commercial real estate adviser to buy from neutral on Sunday, raising its 12-month price target…
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can…
Activist hedge fund Saba Capital Management is preparing to swoop down on three Blue Owl Capital private credit funds, two of which recently offloaded some $1 billion of loan assets, as fears grow over software valuations and a broader liquidity squeeze in private markets. Private credit manager Blue Owl’s share price has fallen sharply in…
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. With the Winter Olympics officially wrapped up, many athletes are leaving Italy with more than just a medal. Stock futures are lower this morning following a winning week for all three major indexes. Here are five key things investors need…
The talent available in the 2026 NFL Draft is better than you think — it is just distributed at different positions than some would prefer. Only two quarterbacks — Indiana’s Fernando Mendoza and Alabama’s Ty Simpson — are listed below. Similarly, Oregon’s Kenyon Sadiq is the only tight end included. But like any class,…
So much has happened this year and yet the market is implying that not much has changed. War warnings, policy reversals, the hunt for AI victims, more than one putative $1 trillion private company looming over the public markets – there’s plenty going on. But in aggregate, portfolios and the economic backdrop are largely unmoved….
Oil retreated from a six-month high on Monday after Oman announced that a third round of talks between Washington and Tehran will continue this week in Geneva. Tensions have remained on high alert throughout the Middle East for weeks after U.S. President Donald Trump indicated a strike on Iran could be imminent. Since then, a…
Check out the companies making headlines before the bell. Arcellx — The biotech stock surged 78% after Gilead Sciences said Monday it agreed to acquire Arcellx for $7.8 billion, offering $115 per share in cash at closing and one contingent value right of $5 per share. Arcellx focuses on immunotherapies for patients with cancer and…
It was a battle of the holdovers at the North American box office this weekend, with the family friendly film “GOAT” edging out the R-rated “Wuthering Heights.” Sony Pictures Animation’s “GOAT” took in $17 million, while Warner Bros.’ “Wuthering Heights” earned $14.2 million, according to studio estimates Sunday. Both films are in their second weekend….
Exterior view of the entrance to Merck headquarters on Feb. 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck said on Monday it will split its human-health business into two divisions, separating its blockbuster cancer franchise led by Keytruda from its non-oncology medicines. The shake-up comes as the drugmaker braces for the…
